One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study

[1] Lachin JM(2014)Impact of C-peptide preservation on metabolic and clinical outcomes in the Diabetes Control and Complications Trial Diabetes. 63 739-748

[2] McGee P(2015)Low levels of C-peptide have clinical significance for established Type 1 diabetes Diabet Med 32 1346-1353

[3] Palmer JP(2020)Mesenchymal Stem Cells Beyond Regenerative Medicine Front Cell Dev Biol 8 72-248

[4] Kuhtreiber WM(2017)Mesenchymal stem cells moderate immune response of type 1 diabetes Cell Tissue Res 368 239-507

[5] Washer SL(2018)Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases Nat Rev Nephrol 14 493-89

[6] Hsu E(2020)The quality evaluation system establishment of mesenchymal stromal cells for cell-based therapy products Stem Cell Res Ther 11 176-156

[7] Zhao M(2013)Mesenchymal stem cell-based therapy Mol Pharm 10 77-151

[8] Reinhold PR(2015)Mesenchymal stromal cells to halt the progression of type 1 diabetes? Curr Diab Rep 15 46-592

[9] Burger D(2016)Infusion with human bone marrow-derived mesenchymal stem cells improves beta-cell function in patients and non-obese mice with severe diabetes Sci Rep 6 37894-357

[10] Shammaa R(2018)Intravenous infusion of human adipose tissue-derived mesenchymal stem cells to treat type 1 diabetic mellitus in mice: an evaluation of grafted cell doses Adv Exp Med Biol 1083 145-2462

[1] Lachin JM(2014)Impact of C-peptide preservation on metabolic and clinical outcomes in the Diabetes Control and Complications Trial Diabetes. 63 739-748

[2] McGee P(2015)Low levels of C-peptide have clinical significance for established Type 1 diabetes Diabet Med 32 1346-1353

[3] Palmer JP(2020)Mesenchymal Stem Cells Beyond Regenerative Medicine Front Cell Dev Biol 8 72-248

[4] Kuhtreiber WM(2017)Mesenchymal stem cells moderate immune response of type 1 diabetes Cell Tissue Res 368 239-507

[5] Washer SL(2018)Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases Nat Rev Nephrol 14 493-89

[6] Hsu E(2020)The quality evaluation system establishment of mesenchymal stromal cells for cell-based therapy products Stem Cell Res Ther 11 176-156

[7] Zhao M(2013)Mesenchymal stem cell-based therapy Mol Pharm 10 77-151

[8] Reinhold PR(2015)Mesenchymal stromal cells to halt the progression of type 1 diabetes? Curr Diab Rep 15 46-592

[9] Burger D(2016)Infusion with human bone marrow-derived mesenchymal stem cells improves beta-cell function in patients and non-obese mice with severe diabetes Sci Rep 6 37894-357

[10] Shammaa R(2018)Intravenous infusion of human adipose tissue-derived mesenchymal stem cells to treat type 1 diabetic mellitus in mice: an evaluation of grafted cell doses Adv Exp Med Biol 1083 145-2462